Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Curtis Cooper

Showing results (201-210 of 268) with videos related to

Pageof 27
Sort By:
Gastroenterology|August 7, 2015
Efficacy of sofosbuvir plus ribavirin with or without peginterferon-alfa in patients with hepatitis C virus genotype 3 infection and treatment-experienced patients with cirrhosis and hepatitis C virus genotype 2 infectionGraham R Foster, Stephen Pianko, Ashley Brown, et al.
Journal of the International Association of Providers of AIDS Care|December 7, 2013
Factors associated with late initiation of highly active antiretroviral therapy among young HIV-positive men and women aged 18 to 29 years in CanadaAlexis K Palmer, Angela Cescon, Keith Chan, et al.
Journal of Viral Hepatitis|December 11, 2020
Distinct Hepatitis B and HIV co-infected populations in CanadaCurtis Cooper, Matt Driedger, David Wong, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 11, 2019
Eliminating Structural Barriers: The Impact of Unrestricted Access on Hepatitis C Treatment Uptake Among People Living With Human Immunodeficiency VirusSahar Saeed, Erin Strumpf, Erica E M Moodie, et al.
Human Vaccines & Immunotherapeutics|July 11, 2013
Safety, immunogenicity, and tolerability of three influenza vaccines in older adults: results of a randomized, controlled comparisonDavid W Scheifele, Shelly A McNeil, Brian J Ward, et al.
CMAJ Open|July 19, 2022
The burden of cancer among people living with HIV in Ontario, Canada, 1997-2020: a retrospective population-based cohort study using administrative health dataIoana A Nicolau, Tony Antoniou, Jennifer D Brooks, et al.
BMC Infectious Diseases|October 23, 2016
Predictors of viral suppression and rebound among HIV-positive men who have sex with men in a large multi-site Canadian cohortZachary Tanner, Nathan Lachowsky, Erin Ding, et al.
Ebiomedicine|December 3, 2021
Relative Ratios of Human Seasonal Coronavirus Antibodies Predict the Efficiency of Cross-Neutralization of SARS-CoV-2 Spike Binding to ACE2Yannick Galipeau, Vinayakumar Siragam, Geneviève Laroche, et al.
The Canadian Journal of Hospital Pharmacy|October 17, 2022
Trends in Use of Combination Antiretroviral Therapy and Treatment Response from 2000 to 2016 in the Canadian Observational Cohort (CANOC): A Longitudinal Cohort StudyAlison R McClean, Jason Trigg, Claudette Cardinal, et al.
Journal of Clinical Pharmacology|December 3, 2014
Interactions of the hepatitis C virus protease inhibitor faldaprevir with cytochrome P450 enzymes: in vitro and in vivo correlationJohn P Sabo, Jens Kort, Charles Ballow, et al.
Pageof 27

Showing results (201-210 of 268) with videos related to

Sort By:
Pageof 27
Gastroenterology|August 7, 2015
Efficacy of sofosbuvir plus ribavirin with or without peginterferon-alfa in patients with hepatitis C virus genotype 3 infection and treatment-experienced patients with cirrhosis and hepatitis C virus genotype 2 infectionGraham R Foster, Stephen Pianko, Ashley Brown, et al.
Journal of the International Association of Providers of AIDS Care|December 7, 2013
Factors associated with late initiation of highly active antiretroviral therapy among young HIV-positive men and women aged 18 to 29 years in CanadaAlexis K Palmer, Angela Cescon, Keith Chan, et al.
Journal of Viral Hepatitis|December 11, 2020
Distinct Hepatitis B and HIV co-infected populations in CanadaCurtis Cooper, Matt Driedger, David Wong, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 11, 2019
Eliminating Structural Barriers: The Impact of Unrestricted Access on Hepatitis C Treatment Uptake Among People Living With Human Immunodeficiency VirusSahar Saeed, Erin Strumpf, Erica E M Moodie, et al.
Human Vaccines & Immunotherapeutics|July 11, 2013
Safety, immunogenicity, and tolerability of three influenza vaccines in older adults: results of a randomized, controlled comparisonDavid W Scheifele, Shelly A McNeil, Brian J Ward, et al.
CMAJ Open|July 19, 2022
The burden of cancer among people living with HIV in Ontario, Canada, 1997-2020: a retrospective population-based cohort study using administrative health dataIoana A Nicolau, Tony Antoniou, Jennifer D Brooks, et al.
BMC Infectious Diseases|October 23, 2016
Predictors of viral suppression and rebound among HIV-positive men who have sex with men in a large multi-site Canadian cohortZachary Tanner, Nathan Lachowsky, Erin Ding, et al.
Ebiomedicine|December 3, 2021
Relative Ratios of Human Seasonal Coronavirus Antibodies Predict the Efficiency of Cross-Neutralization of SARS-CoV-2 Spike Binding to ACE2Yannick Galipeau, Vinayakumar Siragam, Geneviève Laroche, et al.
The Canadian Journal of Hospital Pharmacy|October 17, 2022
Trends in Use of Combination Antiretroviral Therapy and Treatment Response from 2000 to 2016 in the Canadian Observational Cohort (CANOC): A Longitudinal Cohort StudyAlison R McClean, Jason Trigg, Claudette Cardinal, et al.
Journal of Clinical Pharmacology|December 3, 2014
Interactions of the hepatitis C virus protease inhibitor faldaprevir with cytochrome P450 enzymes: in vitro and in vivo correlationJohn P Sabo, Jens Kort, Charles Ballow, et al.
Pageof 27